{"gene":"GAN","run_date":"2026-04-28T18:06:52","timeline":{"discoveries":[{"year":2000,"finding":"Identification of the GAN gene encoding gigaxonin, a novel ubiquitously expressed protein with an N-terminal BTB domain followed by six kelch repeats predicted to form a beta-propeller. Loss-of-function mutations (frameshift, nonsense, and missense) in GAN cause giant axonal neuropathy, a severe autosomal recessive sensorimotor neuropathy characterized by neurofilament accumulation and generalized intermediate filament disorganization (vimentin in fibroblasts/Schwann cells/endothelial cells, GFAP in astrocytes).","method":"Positional cloning, mutation screening (sequencing of GAN patients), domain analysis","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 1-2 — original gene discovery with multiple patient mutations identified and domain architecture established; highly cited foundational study","pmids":["11062483"],"is_preprint":false},{"year":2002,"finding":"Gigaxonin directly binds to the light chain (LC) of microtubule-associated protein 1B (MAP1B-LC) through its C-terminal kelch repeat domain. This interaction was demonstrated by yeast two-hybrid screening, co-transfection, and co-immunoprecipitation. Gigaxonin and MAP1B-LC co-localize in neurons, and their interaction enhances microtubule stability required for axonal transport. At least two GAN patient mutations abolish the gigaxonin-MAP1B-LC interaction.","method":"Yeast two-hybrid screening, co-immunoprecipitation, double immunofluorescence microscopy, ultrastructural analysis, co-transfection","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-IP and yeast two-hybrid with functional validation and disease-mutation disruption, replicated in subsequent studies","pmids":["12147674"],"is_preprint":false},{"year":2005,"finding":"Gigaxonin controls proteasome-dependent degradation of MAP1B-LC by binding to ubiquitin-activating enzyme E1 through its N-terminal BTB domain while engaging MAP1B-LC via its kelch repeats. Overexpression of gigaxonin enhances MAP1B-LC degradation, which is blocked by proteasome inhibitors. Ablation of gigaxonin in GAN-null neurons causes substantial MAP1B-LC accumulation. Overexpression of MAP1B in wild-type neurons causes neuronal death similar to GAN-null neurons, while reducing MAP1B improves survival of null neurons, establishing MAP1B-LC accumulation as a causal mechanism of neurodegeneration.","method":"Co-immunoprecipitation, overexpression/knockdown in cortical neurons, proteasome inhibitor treatment, GAN-null mouse neurons, neuronal survival assays","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods including loss-of-function mouse model, gain-of-function, rescue experiment, and proteasome inhibition; highly cited","pmids":["16227972"],"is_preprint":false},{"year":2005,"finding":"Gigaxonin controls ubiquitin-proteasome-dependent degradation of tubulin folding cofactor B (TBCB). GAN patient mutations impair this function, leading to TBCB protein accumulation. Gigaxonin interacts with TBCB, and this interaction is disrupted by disease-associated GAN mutations, providing a mechanism for the microtubule deficiency (few microtubules) observed in GAN cytoskeletal pathology.","method":"Co-immunoprecipitation, overexpression studies, proteasome inhibition, patient mutation analysis","journal":"Current biology","confidence":"High","confidence_rationale":"Tier 2 — co-IP with functional degradation assay and disease-mutation disruption; independent from MAP1B study, same year","pmids":["16303566"],"is_preprint":false},{"year":2005,"finding":"Gigaxonin (GAN1) is ubiquitinated by a Cul3-dependent E3 ubiquitin ligase complex, establishing gigaxonin as both a substrate adaptor for Cul3 and itself a substrate of this complex. This places gigaxonin within the BTB-Kelch/Cul3 ubiquitin ligase system. Three other BTB-Kelch proteins (Keap1, ENC1, Sarcosin) are similarly ubiquitinated by Cul3-dependent complexes.","method":"In vivo ubiquitination assays, cell-based ubiquitination with Cul3 constructs, immunoblotting","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — direct ubiquitination assay placing GAN1 in Cul3 system; single study but orthogonal methods","pmids":["15983046"],"is_preprint":false},{"year":2007,"finding":"Genotype-phenotype analysis of GAN patients confirms that gigaxonin binds N-terminally to ubiquitin activating enzyme E1 and C-terminally to various microtubule-associated proteins, causing their ubiquitin-mediated degradation. Multiple GAN mutations (splice-site and missense in BTB, BACK, and kelch domains) impede this degradation process, leading to accumulation of microtubule-associated proteins and impaired cellular functions.","method":"Molecular genetic analysis, mutation sequencing across patient cohort (10 patients), literature synthesis with functional interpretation","journal":"Neuromuscular disorders","confidence":"Medium","confidence_rationale":"Tier 3 — genetic/clinical study with mechanistic interpretation based on published functional data; no new biochemical experiments","pmids":["17587580"],"is_preprint":false},{"year":2013,"finding":"Gigaxonin is responsible for ubiquitin-proteasome-dependent degradation of vimentin intermediate filaments (IFs) in fibroblasts and of peripherin and neurofilament IF proteins in neurons. Using GAN patient fibroblasts and Gan-/- mice, gigaxonin loss causes IF protein accumulation. Proteasome inhibition with MG-132 reverses gigaxonin-induced IF clearance, confirming proteasomal involvement. This identifies gigaxonin as a major regulator of cytoskeletal IF degradation and provides a molecular explanation for IF aggregate accumulation in GAN.","method":"Patient fibroblast cultures, Gan-/- mouse neurons, gigaxonin overexpression, MG-132 proteasome inhibition, immunofluorescence, immunoblotting","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 1-2 — multiple cell/animal models with loss-of-function and gain-of-function, proteasome inhibitor rescue, highly cited","pmids":["23585478"],"is_preprint":false},{"year":2016,"finding":"GAN mutations occur in domains associated with protein homodimerization and substrate interaction: the BTB domain, BTB-associated C-terminal BACK domain, and KELCH repeats. Gigaxonin functions as an E3 ubiquitin ligase adaptor protein involved in intermediate filament processing in neural cells and vimentin filaments in fibroblasts. Identical missense and nonsense GAN mutations are found in both GAN patients and cancer cell lines/primary tumors, suggesting shared pathological mechanisms.","method":"Database analysis of cancer genomic sequences (COSMIC, DriverDB, IDGC), comparison with GAN patient mutation database, domain mapping","journal":"Human genetics","confidence":"Low","confidence_rationale":"Tier 4 — primarily computational/database analysis; no new biochemical experiments","pmids":["27023907"],"is_preprint":false},{"year":2023,"finding":"GAN (KLHL16) patient-derived iPSCs reprogrammed to astrocytes, neural progenitor cells (NPCs), and brain organoids reveal that gigaxonin deficiency causes striking perinuclear vimentin and GFAP accumulations and abnormal nuclear morphology in astrocytes. GAN NPCs have lower nestin expression. GAN brain organoids show neurofilament and GFAP aggregates. In overexpression systems, GFAP oligomerization and perinuclear aggregation are augmented in the presence of vimentin. Cells with large perinuclear vimentin aggregates accumulate significantly more nuclear KLHL16 mRNA, suggesting vimentin aggregates trap KLHL16 mRNA. Vimentin is identified as an early effector of KLHL16/gigaxonin mutations.","method":"iPSC reprogramming from GAN patient fibroblasts, CRISPR/Cas9 isogenic controls, NPC and astrocyte differentiation, brain organoids, overexpression assays, immunofluorescence, RNA FISH","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 — patient-derived iPSC model with CRISPR isogenic controls, multiple cell types, orthogonal methods","pmids":["37672338"],"is_preprint":false},{"year":2009,"finding":"Downregulation of Gan1 gene expression and gigaxonin protein levels occurs in mouse spinal dorsal horn in a model of NRTI-induced peripheral neuropathy, suggesting gigaxonin loss-of-function contributes to nerve pathology beyond inherited GAN mutations.","method":"Whole-genome microarray screen, quantitative PCR validation, Western blot in mouse spinal dorsal horn tissue","journal":"Biological research for nursing","confidence":"Low","confidence_rationale":"Tier 3 — expression-level finding with validation but no mechanistic pathway placement beyond expression change","pmids":["19398414"],"is_preprint":false}],"current_model":"Gigaxonin (encoded by GAN/KLHL16) is a BTB-Kelch domain protein that functions as a substrate adaptor for the Cul3-based E3 ubiquitin ligase complex; it binds ubiquitin-activating enzyme E1 through its BTB domain and engages substrates — including MAP1B light chain, TBCB, vimentin, peripherin, and neurofilament proteins — through its kelch repeat beta-propeller domain, targeting them for proteasomal degradation, such that loss-of-function mutations cause pathological accumulation of intermediate filaments and cytoskeletal proteins leading to giant axonal neuropathy."},"narrative":{"teleology":[{"year":2000,"claim":"Positional cloning identified GAN as the causative gene for giant axonal neuropathy, revealing a novel BTB-kelch domain protein whose loss-of-function mutations cause generalized intermediate filament disorganization — establishing that a single E3-adaptor-like protein governs IF homeostasis.","evidence":"Positional cloning and mutation screening in GAN patient families","pmids":["11062483"],"confidence":"High","gaps":["No biochemical substrates or binding partners identified at this stage","Mechanism of IF accumulation unknown"]},{"year":2002,"claim":"Discovery that gigaxonin directly binds MAP1B light chain via its kelch repeats identified the first substrate interaction and linked gigaxonin to microtubule stability and axonal transport, with disease mutations abolishing this binding.","evidence":"Yeast two-hybrid, reciprocal co-IP, co-localization in neurons, disease-mutation disruption","pmids":["12147674"],"confidence":"High","gaps":["Whether gigaxonin promotes MAP1B-LC degradation or merely sequesters it was unclear","Other substrates not yet tested"]},{"year":2005,"claim":"Three convergent studies established gigaxonin as a ubiquitin-proteasome pathway adaptor: it drives proteasomal degradation of MAP1B-LC and TBCB, binds E1 via its BTB domain, and is itself ubiquitinated by a Cul3-dependent complex — placing it firmly in the BTB-Kelch/Cul3 E3 ligase system and demonstrating that substrate accumulation upon gigaxonin loss is directly neurotoxic.","evidence":"GAN-null mouse neurons with rescue and survival assays (MAP1B-LC); co-IP with proteasome inhibitor block (TBCB); in vivo Cul3-dependent ubiquitination assays","pmids":["16227972","16303566","15983046"],"confidence":"High","gaps":["Whether gigaxonin directly ubiquitinates substrates or recruits Cul3 to do so was not resolved biochemically","Intermediate filament proteins not yet tested as substrates","Structural basis of kelch–substrate interaction unknown"]},{"year":2013,"claim":"Extension of gigaxonin's substrate repertoire to intermediate filament proteins — vimentin in fibroblasts and peripherin/neurofilaments in neurons — demonstrated that gigaxonin is a master regulator of IF turnover, not only of MAPs, providing the molecular explanation for the hallmark IF aggregates in GAN.","evidence":"GAN patient fibroblasts, Gan−/− mouse neurons, gigaxonin overexpression/MG-132 proteasome inhibition, immunoblot and immunofluorescence","pmids":["23585478"],"confidence":"High","gaps":["Whether gigaxonin targets all IF classes or only neuronal and type III IFs is unclear","Precise ubiquitination sites on IF substrates not mapped","No reconstituted in vitro ubiquitination assay with purified components"]},{"year":2023,"claim":"Patient iPSC-derived astrocytes and brain organoids revealed that vimentin is the earliest effector of gigaxonin loss, with vimentin aggregates secondarily promoting GFAP accumulation and trapping KLHL16 mRNA — establishing a feed-forward aggregation mechanism in astrocytes.","evidence":"GAN patient iPSC-derived NPCs, astrocytes, and brain organoids with CRISPR isogenic controls; overexpression assays; RNA FISH","pmids":["37672338"],"confidence":"High","gaps":["Whether mRNA trapping by vimentin aggregates reduces gigaxonin protein and worsens pathology in vivo is untested","Contribution of astrocyte dysfunction vs. neuronal pathology to disease progression not delineated","No therapeutic rescue demonstrated in organoid model"]},{"year":null,"claim":"Key open questions include the structural basis of kelch-domain substrate recognition, whether gigaxonin directly assembles a Cul3-RING catalytic complex for substrate ubiquitination (vs. indirect degradation routes), and the relative contribution of individual substrate accumulation to neurodegeneration in vivo.","evidence":"","pmids":[],"confidence":"High","gaps":["No crystal or cryo-EM structure of gigaxonin–substrate complex","No reconstituted Cul3–gigaxonin ubiquitination assay with defined substrates","Relative pathogenic contribution of MAP1B-LC, TBCB, and IF accumulation not resolved in animal models"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[2,3,4,6]},{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[1,2,3,6]}],"localization":[{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[1,6,8]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[2,6]}],"pathway":[{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[2,3,4,6]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[0,2,6,8]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[0,5,8]}],"complexes":["Cul3-BTB-Kelch E3 ubiquitin ligase complex"],"partners":["MAP1B","TBCB","CUL3","VIM","PRPH","GFAP"],"other_free_text":[]},"mechanistic_narrative":"Gigaxonin is a BTB-Kelch substrate adaptor for the Cul3-based E3 ubiquitin ligase complex that targets cytoskeletal and intermediate filament proteins for proteasomal degradation. Its N-terminal BTB domain binds ubiquitin-activating enzyme E1 and mediates Cul3 interaction, while its C-terminal kelch-repeat β-propeller engages substrates including MAP1B light chain, tubulin folding cofactor B (TBCB), vimentin, peripherin, GFAP, and neurofilament proteins, promoting their ubiquitin-dependent turnover [PMID:16227972, PMID:16303566, PMID:23585478]. Loss-of-function mutations in GAN cause giant axonal neuropathy, a severe autosomal recessive sensorimotor neuropathy characterized by pathological accumulation of intermediate filaments and cytoskeletal proteins in neurons, astrocytes, and fibroblasts [PMID:11062483, PMID:37672338]. Patient-derived iPSC models demonstrate that vimentin is an early effector of gigaxonin deficiency, with perinuclear vimentin aggregates driving secondary GFAP accumulation and abnormal nuclear morphology in astrocytes [PMID:37672338]."},"prefetch_data":{"uniprot":{"accession":"Q9H2C0","full_name":"Gigaxonin","aliases":["Kelch-like protein 16"],"length_aa":597,"mass_kda":67.6,"function":"Probable cytoskeletal component that directly or indirectly plays an important role in neurofilament architecture. May act as a substrate-specific adapter of an E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. Controls degradation of TBCB. Controls degradation of MAP1B and MAP1S, and is critical for neuronal maintenance and survival","subcellular_location":"Cytoplasm; Cytoplasm, cytoskeleton","url":"https://www.uniprot.org/uniprotkb/Q9H2C0/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GAN","classification":"Not Classified","n_dependent_lines":16,"n_total_lines":1208,"dependency_fraction":0.013245033112582781},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GAN","total_profiled":1310},"omim":[{"mim_id":"621322","title":"FOXO-INDUCED LONG NONCODING RNA 1; FILNC1","url":"https://www.omim.org/entry/621322"},{"mim_id":"621298","title":"GLYCINE-RICH EXTRACELLULAR PROTEIN 1; GREP1","url":"https://www.omim.org/entry/621298"},{"mim_id":"620911","title":"SPASTIC PARAPLEGIA 92, AUTOSOMAL RECESSIVE; SPG92","url":"https://www.omim.org/entry/620911"},{"mim_id":"620884","title":"FER1-LIKE FAMILY, MEMBER 6; FER1L6","url":"https://www.omim.org/entry/620884"},{"mim_id":"620875","title":"FIC DOMAIN-CONTAINING PROTEIN ADENYLYLTRANSFERASE; FICD","url":"https://www.omim.org/entry/620875"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Microtubules","reliability":"Supported"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"skin 1","ntpm":23.5}],"url":"https://www.proteinatlas.org/search/GAN"},"hgnc":{"alias_symbol":["GAN1","KLHL16","GIG"],"prev_symbol":[]},"alphafold":{"accession":"Q9H2C0","domains":[{"cath_id":"3.30.710.10","chopping":"14-128","consensus_level":"high","plddt":91.1457,"start":14,"end":128},{"cath_id":"1.25.40","chopping":"173-264","consensus_level":"high","plddt":85.1223,"start":173,"end":264},{"cath_id":"2.120.10.80","chopping":"270-586","consensus_level":"medium","plddt":94.4154,"start":270,"end":586}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9H2C0","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9H2C0-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9H2C0-F1-predicted_aligned_error_v6.png","plddt_mean":89.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GAN","jax_strain_url":"https://www.jax.org/strain/search?query=GAN"},"sequence":{"accession":"Q9H2C0","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9H2C0.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9H2C0/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9H2C0"}},"corpus_meta":[{"pmid":"8474442","id":"PMC_8474442","title":"(CT)n (GA)n repeats and heat shock elements have distinct roles in chromatin structure and transcriptional activation of the Drosophila hsp26 gene.","date":"1993","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8474442","citation_count":210,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22710290","id":"PMC_22710290","title":"Mechanism by which ma-xing-shi-gan-tang inhibits the entry of influenza virus.","date":"2012","source":"Journal of ethnopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/22710290","citation_count":100,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32631250","id":"PMC_32631250","title":"Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitis.","date":"2020","source":"BMC gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/32631250","citation_count":98,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2313697","id":"PMC_2313697","title":"Optimal heat-induced expression of the Drosophila hsp26 gene requires a promoter sequence containing (CT)n.(GA)n repeats.","date":"1990","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/2313697","citation_count":85,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31325721","id":"PMC_31325721","title":"TOP-GAN: Stain-free cancer cell classification using deep learning with a small training set.","date":"2019","source":"Medical image analysis","url":"https://pubmed.ncbi.nlm.nih.gov/31325721","citation_count":63,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35143711","id":"PMC_35143711","title":"Hepatoprotective effects of semaglutide, lanifibranor and dietary intervention in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH.","date":"2022","source":"Clinical and translational science","url":"https://pubmed.ncbi.nlm.nih.gov/35143711","citation_count":59,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24384378","id":"PMC_24384378","title":"Chromatographic isolation of nanoparticles from Ma-Xing-Shi-Gan-Tang decoction and their characterization.","date":"2013","source":"Journal of ethnopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/24384378","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32580543","id":"PMC_32580543","title":"Highly Sensitive and Selective Photoelectrochemical Aptasensor for Cancer Biomarker CA125 Based on AuNPs/GaN Schottky Junction.","date":"2020","source":"Analytical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32580543","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32559839","id":"PMC_32559839","title":"Ling-gui-zhu-gan decoction alleviates hepatic steatosis through SOCS2 modification by N6-methyladenosine.","date":"2020","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/32559839","citation_count":47,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34472593","id":"PMC_34472593","title":"PHIAF: prediction of phage-host interactions with GAN-based data augmentation and sequence-based feature fusion.","date":"2022","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/34472593","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16828489","id":"PMC_16828489","title":"The UAA/GAN internal loop motif: a new RNA structural element that forms a cross-strand AAA stack and long-range tertiary interactions.","date":"2006","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16828489","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32221797","id":"PMC_32221797","title":"Combining DC-GAN with ResNet for blood cell image classification.","date":"2020","source":"Medical & biological engineering & computing","url":"https://pubmed.ncbi.nlm.nih.gov/32221797","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33961398","id":"PMC_33961398","title":"Highly Sensitive and Selective Photoelectrochemical Aptasensors for Cancer Biomarkers Based on MoS2/Au/GaN Photoelectrodes.","date":"2021","source":"Analytical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33961398","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28850862","id":"PMC_28850862","title":"Accurate recognition and feature qualify for flavonoid extracts from Liang-wai Gan Cao by liquid chromatography-high resolution-mass spectrometry and computational MS/MS fragmentation.","date":"2017","source":"Journal of pharmaceutical and biomedical analysis","url":"https://pubmed.ncbi.nlm.nih.gov/28850862","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15218322","id":"PMC_15218322","title":"A study on the effects to diabetic nephropathy of Hachimi-jio-gan in rats.","date":"2004","source":"Nephron. Experimental nephrology","url":"https://pubmed.ncbi.nlm.nih.gov/15218322","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18523757","id":"PMC_18523757","title":"Functional reconstitution of the human chemokine receptor CXCR4 with G(i)/G (o)-proteins in Sf9 insect cells.","date":"2008","source":"Naunyn-Schmiedeberg's archives of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/18523757","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38155202","id":"PMC_38155202","title":"Semaglutide reduces tumor burden in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH-HCC with advanced fibrosis.","date":"2023","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/38155202","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32325178","id":"PMC_32325178","title":"Qiang-Gan formula extract improves non-alcoholic steatohepatitis via regulating bile acid metabolism and gut microbiota in mice.","date":"2020","source":"Journal of ethnopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/32325178","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30616587","id":"PMC_30616587","title":"The traditional Chinese formulae Ling-gui-zhu-gan decoction alleviated non-alcoholic fatty liver disease via inhibiting PPP1R3C mediated molecules.","date":"2019","source":"BMC complementary and alternative medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30616587","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33808317","id":"PMC_33808317","title":"iEnhancer-GAN: A Deep Learning Framework in Combination with Word Embedding and Sequence Generative Adversarial Net to Identify Enhancers and Their Strength.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33808317","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17587580","id":"PMC_17587580","title":"Genotype-phenotype analysis in patients with giant axonal neuropathy (GAN).","date":"2007","source":"Neuromuscular disorders : NMD","url":"https://pubmed.ncbi.nlm.nih.gov/17587580","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33407724","id":"PMC_33407724","title":"Lnc-GAN1 expression is associated with good survival and suppresses tumor progression by sponging mir-26a-5p to activate PTEN signaling in non-small cell lung cancer.","date":"2021","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/33407724","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33892068","id":"PMC_33892068","title":"The TCM prescription Ma-xing-shi-gan-tang inhibits Streptococcus pneumoniae pathogenesis by targeting pneumolysin.","date":"2021","source":"Journal of ethnopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/33892068","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18551569","id":"PMC_18551569","title":"Gosha-jinki-gan reduces transmitter proteins and sensory receptors associated with C fiber activation induced by acetic acid in rat urinary bladder.","date":"2008","source":"Neurourology and urodynamics","url":"https://pubmed.ncbi.nlm.nih.gov/18551569","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32663021","id":"PMC_32663021","title":"Optimization of O-GIG for O-Glycopeptide Characterization with Sialic Acid Linkage Determination.","date":"2020","source":"Analytical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32663021","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23425555","id":"PMC_23425555","title":"Direct label free ultrasensitive impedimetric DNA biosensor using dendrimer functionalized GaN nanowires.","date":"2013","source":"Biosensors & bioelectronics","url":"https://pubmed.ncbi.nlm.nih.gov/23425555","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30119204","id":"PMC_30119204","title":"Yu Gan Long reduces rat liver fibrosis by blocking TGF-β1/Smad pathway and modulating the immunity.","date":"2018","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/30119204","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27023907","id":"PMC_27023907","title":"A review of gigaxonin mutations in giant axonal neuropathy (GAN) and cancer.","date":"2016","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27023907","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17473455","id":"PMC_17473455","title":"Effects of Hachimi-jio-gan (Ba-Wei-Di-Huang-Wan) on hyperglycemia in streptozotocin-induced diabetic rats.","date":"2007","source":"Biological & pharmaceutical bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/17473455","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28416706","id":"PMC_28416706","title":"The GAN Exonuclease or the Flap Endonuclease Fen1 and RNase HII Are Necessary for Viability of Thermococcus kodakarensis.","date":"2017","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/28416706","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19398414","id":"PMC_19398414","title":"Genome-wide screen identifies drug-induced regulation of the gene giant axonal neuropathy (Gan) in a mouse model of antiretroviral-induced painful peripheral neuropathy.","date":"2009","source":"Biological research for nursing","url":"https://pubmed.ncbi.nlm.nih.gov/19398414","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15841260","id":"PMC_15841260","title":"Gosha-jinki-gan (a Herbal Complex) Corrects Abnormal Insulin Signaling.","date":"2004","source":"Evidence-based complementary and alternative medicine : eCAM","url":"https://pubmed.ncbi.nlm.nih.gov/15841260","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30846728","id":"PMC_30846728","title":"Daiokanzoto (Da-Huang-Gan-Cao-Tang) is an effective laxative in gut microbiota associated with constipation.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30846728","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30177609","id":"PMC_30177609","title":"Gosha-Jinki-Gan Recovers Spermatogenesis in Mice with Busulfan-Induced Aspermatogenesis.","date":"2018","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30177609","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37387181","id":"PMC_37387181","title":"GAN-based data augmentation for transcriptomics: survey and comparative assessment.","date":"2023","source":"Bioinformatics (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/37387181","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26082617","id":"PMC_26082617","title":"Protective effect of Huang Gan formula in 5/6 nephrectomized rats by depressing the Wnt/β-catenin signaling pathway.","date":"2015","source":"Drug design, development and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/26082617","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29335857","id":"PMC_29335857","title":"Effect of Soothing Gan (Liver) and Invigorating Pi (Spleen) Recipes on TLR4-p38 MAPK Pathway in Kupffer Cells of Non-alcoholic Steatohepatitis Rats.","date":"2018","source":"Chinese journal of integrative medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29335857","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26993050","id":"PMC_26993050","title":"Gan-Lu-Siao-Du-yin, a prescription of traditional Chinese medicine, inhibited enterovirus 71 replication, translation, and virus-induced cell apoptosis.","date":"2016","source":"Journal of ethnopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/26993050","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20527984","id":"PMC_20527984","title":"Effects of a Chinese herbal health formula, \"Gan-Lu-Yin\", on angiogenesis.","date":"2010","source":"Journal of agricultural and food chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20527984","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29876741","id":"PMC_29876741","title":"Two novel mutations in the GAN gene causing giant axonal neuropathy.","date":"2018","source":"World journal of pediatrics : WJP","url":"https://pubmed.ncbi.nlm.nih.gov/29876741","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36124302","id":"PMC_36124302","title":"Single-cell multi-modal GAN reveals spatial patterns in single-cell data from triple-negative breast cancer.","date":"2022","source":"Patterns (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/36124302","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32627816","id":"PMC_32627816","title":"Ma xing shi gan decoction eliminates PM2.5-induced lung injury by reducing pulmonary cell apoptosis through Akt/mTOR/p70S6K pathway in rats.","date":"2020","source":"Bioscience reports","url":"https://pubmed.ncbi.nlm.nih.gov/32627816","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38205394","id":"PMC_38205394","title":"Huang Gan Formula Alleviates Systemic Inflammation and Uremia in Adenine-Induced Chronic Kidney Disease Rats May Associate with Modification of Gut Microbiota and Colonic Microenvironment.","date":"2024","source":"Drug design, development and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/38205394","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38308212","id":"PMC_38308212","title":"Dietary intervention reverses molecular markers of hepatocellular senescence in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH.","date":"2024","source":"BMC gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/38308212","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23332420","id":"PMC_23332420","title":"A novel mutation in the GAN gene causes an intermediate form of giant axonal neuropathy in an Arab-Israeli family.","date":"2013","source":"European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society","url":"https://pubmed.ncbi.nlm.nih.gov/23332420","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35640972","id":"PMC_35640972","title":"Effector-GAN: prediction of fungal effector proteins based on pretrained deep representation learning methods and generative adversarial networks.","date":"2022","source":"Bioinformatics (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/35640972","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38647315","id":"PMC_38647315","title":"Ling-Gui-Zhu-Gan decoction ameliorates nonalcoholic fatty liver disease via modulating the gut microbiota.","date":"2024","source":"Microbiology spectrum","url":"https://pubmed.ncbi.nlm.nih.gov/38647315","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27108711","id":"PMC_27108711","title":"Electronic and chemical structure of the H2O/GaN(0001) interface under ambient conditions.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27108711","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35038653","id":"PMC_35038653","title":"iPro-GAN: A novel model based on generative adversarial learning for identifying promoters and their strength.","date":"2022","source":"Computer methods and programs in biomedicine","url":"https://pubmed.ncbi.nlm.nih.gov/35038653","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20056141","id":"PMC_20056141","title":"Herb medicine Gan-fu-kang attenuates liver injury in a rat fibrotic model.","date":"2010","source":"Journal of ethnopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/20056141","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39161892","id":"PMC_39161892","title":"Pharmacological mechanisms of Ma Xing Shi Gan Decoction in treating influenza virus-induced pneumonia: intestinal microbiota and pulmonary glycolysis.","date":"2024","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/39161892","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32138301","id":"PMC_32138301","title":"Co-Administration of the Traditional Medicines Hachimi-Jio-Gan and Hochu-Ekki-To Can Reverse Busulfan-Induced Aspermatogenesis.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32138301","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39144217","id":"PMC_39144217","title":"The potential linkage between sediment oxygen demand and microbes and its contribution to the dissolved oxygen depletion in the Gan River.","date":"2024","source":"Frontiers in microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/39144217","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37066021","id":"PMC_37066021","title":"MutaGAN: A sequence-to-sequence GAN framework to predict mutations of evolving protein populations.","date":"2023","source":"Virus evolution","url":"https://pubmed.ncbi.nlm.nih.gov/37066021","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24809288","id":"PMC_24809288","title":"Anti-tumor effect of Shu-Gan-Liang-Xue decoction in breast cancer is related to the inhibition of aromatase and steroid sulfatase expression.","date":"2014","source":"Journal of ethnopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/24809288","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18469482","id":"PMC_18469482","title":"Herbal medicine, Hachimi-jio-gan, and its component cinnamomi cortex activate the peroxisome proliferator-activated receptor alpha in renal cells.","date":"2008","source":"Endocrine journal","url":"https://pubmed.ncbi.nlm.nih.gov/18469482","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35247474","id":"PMC_35247474","title":"The effect of Ma-Xin-Gan-Shi decoction on asthma exacerbated by respiratory syncytial virus through regulating TRPV1 channel.","date":"2022","source":"Journal of ethnopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/35247474","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35577161","id":"PMC_35577161","title":"Network pharmacology analysis on mechanism of Jian Pi Qing Gan Yin decoction ameliorating high fat diet-induced non-alcoholic fatty liver disease and validated in vivo.","date":"2022","source":"Journal of ethnopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/35577161","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33190414","id":"PMC_33190414","title":"Vimentin's side gig: Regulating cellular proteostasis in mammalian systems.","date":"2020","source":"Cytoskeleton (Hoboken, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/33190414","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27549769","id":"PMC_27549769","title":"Bo-Gan-Whan regulates proliferation and migration of vascular smooth muscle cells.","date":"2016","source":"BMC complementary and alternative medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27549769","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38317025","id":"PMC_38317025","title":"AGImpute: imputation of scRNA-seq data based on a hybrid GAN with dropouts identification.","date":"2024","source":"Bioinformatics (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/38317025","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33712675","id":"PMC_33712675","title":"From rumor to genetic mutation detection with explanations: a GAN approach.","date":"2021","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/33712675","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33905431","id":"PMC_33905431","title":"Increasing prediction accuracy of pathogenic staging by sample augmentation with a GAN.","date":"2021","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/33905431","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17766103","id":"PMC_17766103","title":"AlGaN/GaN heterostructures for non-invasive cell electrophysiological measurements.","date":"2007","source":"Biosensors & bioelectronics","url":"https://pubmed.ncbi.nlm.nih.gov/17766103","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33935715","id":"PMC_33935715","title":"Comprehensive RNA-Seq Analysis of Potential Therapeutic Targets of Gan-Dou-Fu-Mu Decoction for Treatment of Wilson Disease Using a Toxic Milk Mouse Model.","date":"2021","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/33935715","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35924980","id":"PMC_35924980","title":"3D GAN image synthesis and dataset quality assessment for bacterial biofilm.","date":"2022","source":"Bioinformatics (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/35924980","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33288019","id":"PMC_33288019","title":"Glycyrrhizin, the active compound of the TCM drug Gan Cao stimulates actin remodelling and defence in grapevine.","date":"2020","source":"Plant science : an international journal of experimental plant biology","url":"https://pubmed.ncbi.nlm.nih.gov/33288019","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40311598","id":"PMC_40311598","title":"Intestinal IL-17 family orchestrates microbiota-driven histone deacetylation and promotes Treg differentiation to mediate the alleviation of asthma by Ma-Xing-Shi-Gan decoction.","date":"2025","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/40311598","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28463986","id":"PMC_28463986","title":"The Legionella pneumophila GIG operon responds to gold and copper in planktonic and biofilm cultures.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/28463986","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40305974","id":"PMC_40305974","title":"Vitality attributes and their associations with intrinsic capacity, resilience, and happiness in community-dwelling adults: Results from Gan-Dau Healthy Longevity Plan Wave 2.","date":"2025","source":"The journal of nutrition, health & aging","url":"https://pubmed.ncbi.nlm.nih.gov/40305974","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16107322","id":"PMC_16107322","title":"Hepatoprotective mechanisms of Yan-gan-wan.","date":"2005","source":"Hepatology research : the official journal of the Japan Society of Hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/16107322","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36716903","id":"PMC_36716903","title":"Therapeutic effects and mechanisms of Ku-Gan formula on atopic dermatitis: A pilot clinical study and modular pharmacology analysis with animal validation.","date":"2023","source":"Journal of ethnopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/36716903","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23573143","id":"PMC_23573143","title":"Gan-Lu-Yin Inhibits Proliferation and Migration of Murine WEHI-3 Leukemia Cells and Tumor Growth in BALB/C Allograft Tumor Model.","date":"2013","source":"Evidence-based complementary and alternative medicine : eCAM","url":"https://pubmed.ncbi.nlm.nih.gov/23573143","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33083995","id":"PMC_33083995","title":"Go-sha-jinki-Gan Alleviates Inflammation in Neurological Disorders via p38-TNF Signaling in the Central Nervous System.","date":"2020","source":"Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/33083995","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37672338","id":"PMC_37672338","title":"Intermediate filament dysregulation in astrocytes in the human disease model of KLHL16 mutation in giant axonal neuropathy (GAN).","date":"2023","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/37672338","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38241142","id":"PMC_38241142","title":"Ling-Gui-Zhu-Gan decoction protects against doxorubicin-induced myocardial injury by downregulating ferroptosis.","date":"2024","source":"The Journal of pharmacy and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/38241142","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25264283","id":"PMC_25264283","title":"Enhanced cell growth on nanotextured GaN surface treated by UV illumination and fibronectin adsorption.","date":"2014","source":"Colloids and surfaces. B, Biointerfaces","url":"https://pubmed.ncbi.nlm.nih.gov/25264283","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35404518","id":"PMC_35404518","title":"A Versatile, Incubator-Compatible, Monolithic GaN Photonic Chipscope for Label-Free Monitoring of Live Cell Activities.","date":"2022","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/35404518","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34889507","id":"PMC_34889507","title":"Giant axonal neuropathy (GAN) in an 8-year-old girl caused by a homozygous pathogenic splicing variant in GAN gene.","date":"2021","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/34889507","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36828197","id":"PMC_36828197","title":"The protective effects of Zhi-Gan-Cao-Tang against diabetic myocardial infarction injury and identification of its effective constituents.","date":"2023","source":"Journal of ethnopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/36828197","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35161241","id":"PMC_35161241","title":"Major Plant in Herbal Mixture Gan-Mai-Da-Zao for the Alleviation of Depression in Rat Models.","date":"2022","source":"Plants (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/35161241","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23243456","id":"PMC_23243456","title":"Rokumi-jio-gan-Containing Prescriptions Attenuate Oxidative Stress, Inflammation, and Apoptosis in the Remnant Kidney.","date":"2012","source":"Evidence-based complementary and alternative medicine : eCAM","url":"https://pubmed.ncbi.nlm.nih.gov/23243456","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38034402","id":"PMC_38034402","title":"SIGANEO: Similarity network with GAN enhancement for immunogenic neoepitope prediction.","date":"2023","source":"Computational and structural biotechnology journal","url":"https://pubmed.ncbi.nlm.nih.gov/38034402","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22241503","id":"PMC_22241503","title":"Effect and mechanisms of Gong-tone music on the immunological function in rats with Liver (Gan)-qi depression and Spleen (Pi)-qi deficiency syndrome in rats.","date":"2012","source":"Chinese journal of integrative medicine","url":"https://pubmed.ncbi.nlm.nih.gov/22241503","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37655766","id":"PMC_37655766","title":"First-principles study of controllable contact types in Janus MoSH/GaN van der Waals heterostructure.","date":"2023","source":"The Journal of chemical physics","url":"https://pubmed.ncbi.nlm.nih.gov/37655766","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39574280","id":"PMC_39574280","title":"Intrinsic Capacity Impairments (ICOPE Step 1 and Step 2), Cardiometabolic Risk and Immune Resilience: An Exploratory Analysis from the Gan-Dau Healthy Longevity Plan.","date":"2024","source":"The Journal of frailty & aging","url":"https://pubmed.ncbi.nlm.nih.gov/39574280","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34950216","id":"PMC_34950216","title":"Shu-Di-Huang and Gan-Cao Herb Pair Restored the Differentiation Potentials of Mesenchymal Stem Progenitors in Treating Osteoporosis via Downregulation of NF-κB Signaling Pathway.","date":"2021","source":"Evidence-based complementary and alternative medicine : eCAM","url":"https://pubmed.ncbi.nlm.nih.gov/34950216","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23467843","id":"PMC_23467843","title":"Shu-Gan-Liang-Xue Decoction Simultaneously Down-regulates Expressions of Aromatase and Steroid Sulfatase in Estrogen Receptor Positive Breast Cancer Cells.","date":"2011","source":"Chinese journal of cancer research = Chung-kuo yen cheng yen chiu","url":"https://pubmed.ncbi.nlm.nih.gov/23467843","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36762105","id":"PMC_36762105","title":"Exploring the molecular mechanism of Gan Shuang granules for the treatment of non-alcoholic steatohepatitis using network pharmacology, molecular docking, and experimental verification.","date":"2023","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/36762105","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39224696","id":"PMC_39224696","title":"Metabolic profile and bioactivity of the peel of Zhoupigan (Citrus reticulata cv. Manau Gan), a special citrus variety in China, based on GC-MS, UPLC-ESI-MS/MS analysis, and in vitro assay.","date":"2024","source":"Food chemistry: X","url":"https://pubmed.ncbi.nlm.nih.gov/39224696","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40750975","id":"PMC_40750975","title":"Novel dual gland GAN architecture improves human protein localization classification using salivary and pituitary gland inspired loss functions.","date":"2025","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/40750975","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37926662","id":"PMC_37926662","title":"HER2GAN: Overcome the Scarcity of HER2 Breast Cancer Dataset Based on Transfer Learning and GAN Model.","date":"2023","source":"Clinical breast cancer","url":"https://pubmed.ncbi.nlm.nih.gov/37926662","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32150368","id":"PMC_32150368","title":"Modified p-GaN Microwells with Vertically Aligned 2D-MoS2 for Enhanced Photoelectrochemical Water Splitting.","date":"2020","source":"ACS applied materials & interfaces","url":"https://pubmed.ncbi.nlm.nih.gov/32150368","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35586687","id":"PMC_35586687","title":"Clinical Evidence and Potential Mechanisms of Complementary Treatment of Ling Gui Zhu Gan Formula for the Management of Serum Lipids and Obesity.","date":"2022","source":"Evidence-based complementary and alternative medicine : eCAM","url":"https://pubmed.ncbi.nlm.nih.gov/35586687","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36961137","id":"PMC_36961137","title":"Exploring the molecular mechanism of Ling-Gui-Zhu-Gan decoction for the treatment of type 2 diabetes mellitus based on network pharmacology and molecular docking: A review.","date":"2023","source":"Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36961137","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35990498","id":"PMC_35990498","title":"Integrating UPLC-HR-MS/MS, Network Pharmacology, and Experimental Validation to Uncover the Mechanisms of Jin'gan Capsules against Breast Cancer.","date":"2022","source":"ACS omega","url":"https://pubmed.ncbi.nlm.nih.gov/35990498","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38043753","id":"PMC_38043753","title":"Molecular mechanism of Gan-song Yin inhibiting the proliferation of renal tubular epithelial cells by regulating miR-21-5p in adipocyte exosomes.","date":"2023","source":"Journal of ethnopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/38043753","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37251232","id":"PMC_37251232","title":"Role of PGC-1α mediated synaptic plasticity, mitochondrial function, and neuroinflammation in the antidepressant effect of Zi-Shui-Qing-Gan-Yin.","date":"2023","source":"Frontiers in neurology","url":"https://pubmed.ncbi.nlm.nih.gov/37251232","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32158379","id":"PMC_32158379","title":"Identification of Novel Compound Heterozygous Mutations in the GAN Gene of a Chinese Patient Diagnosed With Giant Axonal Neuropathy.","date":"2020","source":"Frontiers in neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/32158379","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32288936","id":"PMC_32288936","title":"Detection of Severe Acute Respiratory Syndrome (SARS) Coronavirus Nucleocapsid Protein Using AlGaN/GaN High Electron Mobility Transistors.","date":"2013","source":"ECS transactions","url":"https://pubmed.ncbi.nlm.nih.gov/32288936","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17081983","id":"PMC_17081983","title":"Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.","date":"2006","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/17081983","citation_count":2861,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20562859","id":"PMC_20562859","title":"Network organization of the human autophagy system.","date":"2010","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/20562859","citation_count":1286,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29507755","id":"PMC_29507755","title":"VIRMA mediates preferential m6A mRNA methylation in 3'UTR and near stop codon and associates with alternative polyadenylation.","date":"2018","source":"Cell discovery","url":"https://pubmed.ncbi.nlm.nih.gov/29507755","citation_count":829,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14702039","id":"PMC_14702039","title":"Complete sequencing and characterization of 21,243 full-length human cDNAs.","date":"2003","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14702039","citation_count":754,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22939624","id":"PMC_22939624","title":"Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22939624","citation_count":708,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35271311","id":"PMC_35271311","title":"OpenCell: Endogenous tagging for the cartography of human cellular organization.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35271311","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14744259","id":"PMC_14744259","title":"14-3-3-affinity purification of over 200 human phosphoproteins reveals new links to regulation of cellular metabolism, proliferation and trafficking.","date":"2004","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/14744259","citation_count":372,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25036637","id":"PMC_25036637","title":"A quantitative chaperone interaction network reveals the architecture of cellular protein homeostasis pathways.","date":"2014","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/25036637","citation_count":325,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11062483","id":"PMC_11062483","title":"The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonal neuropathy.","date":"2000","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11062483","citation_count":322,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21145461","id":"PMC_21145461","title":"Dynamics of cullin-RING ubiquitin ligase network revealed by systematic quantitative proteomics.","date":"2010","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/21145461","citation_count":318,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15983046","id":"PMC_15983046","title":"Ubiquitination of Keap1, a BTB-Kelch substrate adaptor protein for Cul3, targets Keap1 for degradation by a proteasome-independent pathway.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15983046","citation_count":256,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23676014","id":"PMC_23676014","title":"Update on the Kelch-like (KLHL) gene family.","date":"2013","source":"Human genomics","url":"https://pubmed.ncbi.nlm.nih.gov/23676014","citation_count":211,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27173435","id":"PMC_27173435","title":"An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/27173435","citation_count":211,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15778465","id":"PMC_15778465","title":"Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer.","date":"2005","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/15778465","citation_count":153,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"36217030","id":"PMC_36217030","title":"A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets.","date":"2022","source":"Nature biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/36217030","citation_count":140,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16227972","id":"PMC_16227972","title":"Gigaxonin-controlled degradation of MAP1B light chain is critical to neuronal survival.","date":"2005","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/16227972","citation_count":114,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20379614","id":"PMC_20379614","title":"Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.","date":"2010","source":"Molecular medicine (Cambridge, Mass.)","url":"https://pubmed.ncbi.nlm.nih.gov/20379614","citation_count":108,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23585478","id":"PMC_23585478","title":"Giant axonal neuropathy-associated gigaxonin mutations impair intermediate filament protein degradation.","date":"2013","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/23585478","citation_count":108,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12147674","id":"PMC_12147674","title":"Microtubule-associated protein 1B: a neuronal binding partner for gigaxonin.","date":"2002","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/12147674","citation_count":79,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32814053","id":"PMC_32814053","title":"Interactome Mapping Provides a Network of Neurodegenerative Disease Proteins and Uncovers Widespread Protein Aggregation in Affected Brains.","date":"2020","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/32814053","citation_count":79,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16303566","id":"PMC_16303566","title":"Gigaxonin interacts with tubulin folding cofactor B and controls its degradation through the ubiquitin-proteasome pathway.","date":"2005","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/16303566","citation_count":75,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29859926","id":"PMC_29859926","title":"E3 Ligase Trim21 Ubiquitylates and Stabilizes Keratin 17 to Induce STAT3 Activation in Psoriasis.","date":"2018","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/29859926","citation_count":73,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35831314","id":"PMC_35831314","title":"Scalable multiplex co-fractionation/mass spectrometry platform for accelerated protein interactome discovery.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35831314","citation_count":65,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29249570","id":"PMC_29249570","title":"Cullin 3-Based Ubiquitin Ligases as Master Regulators of Mammalian Cell Differentiation.","date":"2017","source":"Trends in biochemical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/29249570","citation_count":59,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"31300519","id":"PMC_31300519","title":"PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation.","date":"2019","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/31300519","citation_count":58,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":55839,"output_tokens":1484,"usd":0.094889},"stage2":{"model":"claude-opus-4-6","input_tokens":4717,"output_tokens":1630,"usd":0.096503},"total_usd":0.440721,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":68609,"output_tokens":3454,"usd":0.128819},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":6388,"output_tokens":1936,"usd":0.12051}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2007,\n      \"finding\": \"Gigaxonin (GAN gene product) functions as an E3 ubiquitin ligase adaptor protein: it binds N-terminally to ubiquitin activating enzyme E1 and C-terminally to various microtubule-associated proteins, causing their ubiquitin-mediated degradation. Mutations in gigaxonin impede this process, leading to accumulation of microtubule-associated proteins and impairment of cellular functions.\",\n      \"method\": \"Genotype-phenotype analysis combined with prior biochemical characterization of gigaxonin-protein interactions\",\n      \"journal\": \"Neuromuscular disorders : NMD\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — cited summary of prior biochemical findings; single report, no direct in vitro reconstitution in this paper\",\n      \"pmids\": [\"17587580\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Gigaxonin is an E3 ubiquitin ligase adaptor protein involved in intermediate filament processing in neural cells and vimentin filament turnover in fibroblasts. Mutations in the BTB, BACK, and KELCH repeat domains (involved in protein homodimerization and substrate interaction) disrupt this function, causing accumulation of neurofilaments and formation of giant axons.\",\n      \"method\": \"Database analysis of GAN mutations combined with prior functional studies; domain mapping\",\n      \"journal\": \"Human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — review/database analysis citing established biochemical roles; moderate evidence from multiple prior studies\",\n      \"pmids\": [\"27023907\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Downregulation of the Gan1 gene and its protein product gigaxonin occurs in the spinal dorsal horn in a mouse model of nucleoside reverse transcriptase inhibitor-induced neuropathy, establishing a link between gigaxonin loss and drug-induced peripheral neuropathy.\",\n      \"method\": \"Genome-wide microarray screen followed by qPCR and Western blot validation in mouse spinal dorsal horn tissue\",\n      \"journal\": \"Biological research for nursing\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, expression-level validation with no direct mechanistic dissection\",\n      \"pmids\": [\"19398414\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"KLHL16 (GAN gene) mutations in giant axonal neuropathy cause dysregulation of intermediate filament turnover in astrocytes, with striking perinuclear vimentin and GFAP accumulations. In over-expression systems, GFAP oligomerization and perinuclear aggregation were augmented in the presence of vimentin, and cells with large perinuclear vimentin aggregates accumulated significantly more nuclear KLHL16 mRNA. GAN iPSC-astrocytes were deficient for gigaxonin protein.\",\n      \"method\": \"iPSC differentiation to astrocytes and brain organoids from GAN patient fibroblasts, CRISPR/Cas9 isogenic controls, immunofluorescence, overexpression systems, FISH for nuclear mRNA\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods in patient-derived and isogenic control cells, functional validation\",\n      \"pmids\": [\"37672338\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"A splice-site mutation in the GAN gene (c.1373+1G>A) leads to skipping of exon 8 and disrupts formation of the Kelch domain of gigaxonin, establishing that the Kelch domain is required for normal gigaxonin function and that its loss causes the GAN phenotype.\",\n      \"method\": \"Whole-exome sequencing, cDNA-level validation of aberrant splicing, clinical phenotyping\",\n      \"journal\": \"American journal of medical genetics. Part A\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single patient/family, splicing mechanism validated at cDNA level\",\n      \"pmids\": [\"34889507\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Compound heterozygous mutations in the GAN gene (p.S79L in the BTB domain and p.T489S in the Kelch domain) affect conserved residues and alter predicted protein crystal structures, and the classical GAN axonal phenotype (swollen axons filled with neurofilaments) is observed in sural nerve biopsy of the affected patient.\",\n      \"method\": \"Next-generation sequencing, bioinformatics structural prediction, sural nerve biopsy histology\",\n      \"journal\": \"Frontiers in neuroscience\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single patient, structural prediction is computational; histology confirms phenotype but mechanism is inferred\",\n      \"pmids\": [\"32158379\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"Gigaxonin (encoded by GAN/KLHL16) functions as an E3 ubiquitin ligase adaptor protein that binds ubiquitin activating enzyme E1 via its N-terminus and microtubule-associated proteins and intermediate filaments (including neurofilaments and vimentin) via its C-terminal Kelch repeat domain, targeting them for ubiquitin-proteasome-mediated degradation; loss-of-function mutations in GAN disrupt this degradation pathway, causing pathological accumulation of intermediate filaments in axons and astrocytes, resulting in giant axonal neuropathy.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll systematically classify each paper before extracting discoveries.\n\n**Classification:**\n\nFrom the main corpus (100 papers):\n- Papers about GAN (gigaxonin/giant axonal neuropathy gene): #21, #28, #31, #40, #45, #75, #79, #99 → KEEP\n- Paper #22 (lnc-GAN1): EXCLUDE — case (B) alt-locus product (lncRNA transcribed from GAN locus, not the protein)\n- Paper #30: GAN = \"GINS-associated nuclease\" in Archaea → EXCLUDE — case (A) alias collision (archaeal enzyme, incompatible function/organism)\n- All other papers: various TCM formulas (Gan = liver in Chinese), GAN diet (Gubra-Amylin NASH), gallium nitride (GaN), machine learning GANs, Drosophila hsp26/GAGA factor, RNA motifs, etc. → EXCLUDE\n\nFrom gene2pubmed-curated papers:\n- #14 (Bomont 2000, PMID 11062483): Discovery of GAN gene/gigaxonin → KEEP\n- #21 (Allen 2005, PMID 16227972): Gigaxonin controls MAP1B-LC degradation → KEEP\n- #23 (Mahammad 2013, PMID 23585478): Gigaxonin degrades IF proteins → KEEP\n- #24 (Ding 2002, PMID 12147674): MAP1B-LC binding partner → KEEP\n- #26 (Wang 2005, PMID 16303566): TBCB degradation by gigaxonin → KEEP\n- #16 (Zhang 2005, PMID 15983046): GAN1/gigaxonin ubiquitinated by Cul3 → KEEP\n- #17 (Dhanoa 2013, PMID 23676014): KLHL family/BTB-Kelch → KEEP (mechanistic context for gigaxonin)\n- #29 (Dubiel 2017, PMID 29249570): CRL3 complexes → relevant context but no GAN-specific mechanism → EXCLUDE\n- All large proteomics/interactome papers (BioPlex, etc.): no GAN-specific mechanism → EXCLUDE\n- #27 (Yang 2018, PMID 29859926): About K17/TRIM21, not GAN → EXCLUDE\n- All others: not GAN-specific → EXCLUDE\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2000,\n      \"finding\": \"Identification of the GAN gene encoding gigaxonin, a novel ubiquitously expressed protein with an N-terminal BTB domain followed by six kelch repeats predicted to form a beta-propeller. Loss-of-function mutations (frameshift, nonsense, and missense) in GAN cause giant axonal neuropathy, a severe autosomal recessive sensorimotor neuropathy characterized by neurofilament accumulation and generalized intermediate filament disorganization (vimentin in fibroblasts/Schwann cells/endothelial cells, GFAP in astrocytes).\",\n      \"method\": \"Positional cloning, mutation screening (sequencing of GAN patients), domain analysis\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — original gene discovery with multiple patient mutations identified and domain architecture established; highly cited foundational study\",\n      \"pmids\": [\"11062483\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Gigaxonin directly binds to the light chain (LC) of microtubule-associated protein 1B (MAP1B-LC) through its C-terminal kelch repeat domain. This interaction was demonstrated by yeast two-hybrid screening, co-transfection, and co-immunoprecipitation. Gigaxonin and MAP1B-LC co-localize in neurons, and their interaction enhances microtubule stability required for axonal transport. At least two GAN patient mutations abolish the gigaxonin-MAP1B-LC interaction.\",\n      \"method\": \"Yeast two-hybrid screening, co-immunoprecipitation, double immunofluorescence microscopy, ultrastructural analysis, co-transfection\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP and yeast two-hybrid with functional validation and disease-mutation disruption, replicated in subsequent studies\",\n      \"pmids\": [\"12147674\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Gigaxonin controls proteasome-dependent degradation of MAP1B-LC by binding to ubiquitin-activating enzyme E1 through its N-terminal BTB domain while engaging MAP1B-LC via its kelch repeats. Overexpression of gigaxonin enhances MAP1B-LC degradation, which is blocked by proteasome inhibitors. Ablation of gigaxonin in GAN-null neurons causes substantial MAP1B-LC accumulation. Overexpression of MAP1B in wild-type neurons causes neuronal death similar to GAN-null neurons, while reducing MAP1B improves survival of null neurons, establishing MAP1B-LC accumulation as a causal mechanism of neurodegeneration.\",\n      \"method\": \"Co-immunoprecipitation, overexpression/knockdown in cortical neurons, proteasome inhibitor treatment, GAN-null mouse neurons, neuronal survival assays\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods including loss-of-function mouse model, gain-of-function, rescue experiment, and proteasome inhibition; highly cited\",\n      \"pmids\": [\"16227972\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Gigaxonin controls ubiquitin-proteasome-dependent degradation of tubulin folding cofactor B (TBCB). GAN patient mutations impair this function, leading to TBCB protein accumulation. Gigaxonin interacts with TBCB, and this interaction is disrupted by disease-associated GAN mutations, providing a mechanism for the microtubule deficiency (few microtubules) observed in GAN cytoskeletal pathology.\",\n      \"method\": \"Co-immunoprecipitation, overexpression studies, proteasome inhibition, patient mutation analysis\",\n      \"journal\": \"Current biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — co-IP with functional degradation assay and disease-mutation disruption; independent from MAP1B study, same year\",\n      \"pmids\": [\"16303566\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Gigaxonin (GAN1) is ubiquitinated by a Cul3-dependent E3 ubiquitin ligase complex, establishing gigaxonin as both a substrate adaptor for Cul3 and itself a substrate of this complex. This places gigaxonin within the BTB-Kelch/Cul3 ubiquitin ligase system. Three other BTB-Kelch proteins (Keap1, ENC1, Sarcosin) are similarly ubiquitinated by Cul3-dependent complexes.\",\n      \"method\": \"In vivo ubiquitination assays, cell-based ubiquitination with Cul3 constructs, immunoblotting\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct ubiquitination assay placing GAN1 in Cul3 system; single study but orthogonal methods\",\n      \"pmids\": [\"15983046\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Genotype-phenotype analysis of GAN patients confirms that gigaxonin binds N-terminally to ubiquitin activating enzyme E1 and C-terminally to various microtubule-associated proteins, causing their ubiquitin-mediated degradation. Multiple GAN mutations (splice-site and missense in BTB, BACK, and kelch domains) impede this degradation process, leading to accumulation of microtubule-associated proteins and impaired cellular functions.\",\n      \"method\": \"Molecular genetic analysis, mutation sequencing across patient cohort (10 patients), literature synthesis with functional interpretation\",\n      \"journal\": \"Neuromuscular disorders\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — genetic/clinical study with mechanistic interpretation based on published functional data; no new biochemical experiments\",\n      \"pmids\": [\"17587580\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Gigaxonin is responsible for ubiquitin-proteasome-dependent degradation of vimentin intermediate filaments (IFs) in fibroblasts and of peripherin and neurofilament IF proteins in neurons. Using GAN patient fibroblasts and Gan-/- mice, gigaxonin loss causes IF protein accumulation. Proteasome inhibition with MG-132 reverses gigaxonin-induced IF clearance, confirming proteasomal involvement. This identifies gigaxonin as a major regulator of cytoskeletal IF degradation and provides a molecular explanation for IF aggregate accumulation in GAN.\",\n      \"method\": \"Patient fibroblast cultures, Gan-/- mouse neurons, gigaxonin overexpression, MG-132 proteasome inhibition, immunofluorescence, immunoblotting\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple cell/animal models with loss-of-function and gain-of-function, proteasome inhibitor rescue, highly cited\",\n      \"pmids\": [\"23585478\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"GAN mutations occur in domains associated with protein homodimerization and substrate interaction: the BTB domain, BTB-associated C-terminal BACK domain, and KELCH repeats. Gigaxonin functions as an E3 ubiquitin ligase adaptor protein involved in intermediate filament processing in neural cells and vimentin filaments in fibroblasts. Identical missense and nonsense GAN mutations are found in both GAN patients and cancer cell lines/primary tumors, suggesting shared pathological mechanisms.\",\n      \"method\": \"Database analysis of cancer genomic sequences (COSMIC, DriverDB, IDGC), comparison with GAN patient mutation database, domain mapping\",\n      \"journal\": \"Human genetics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 — primarily computational/database analysis; no new biochemical experiments\",\n      \"pmids\": [\"27023907\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"GAN (KLHL16) patient-derived iPSCs reprogrammed to astrocytes, neural progenitor cells (NPCs), and brain organoids reveal that gigaxonin deficiency causes striking perinuclear vimentin and GFAP accumulations and abnormal nuclear morphology in astrocytes. GAN NPCs have lower nestin expression. GAN brain organoids show neurofilament and GFAP aggregates. In overexpression systems, GFAP oligomerization and perinuclear aggregation are augmented in the presence of vimentin. Cells with large perinuclear vimentin aggregates accumulate significantly more nuclear KLHL16 mRNA, suggesting vimentin aggregates trap KLHL16 mRNA. Vimentin is identified as an early effector of KLHL16/gigaxonin mutations.\",\n      \"method\": \"iPSC reprogramming from GAN patient fibroblasts, CRISPR/Cas9 isogenic controls, NPC and astrocyte differentiation, brain organoids, overexpression assays, immunofluorescence, RNA FISH\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — patient-derived iPSC model with CRISPR isogenic controls, multiple cell types, orthogonal methods\",\n      \"pmids\": [\"37672338\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Downregulation of Gan1 gene expression and gigaxonin protein levels occurs in mouse spinal dorsal horn in a model of NRTI-induced peripheral neuropathy, suggesting gigaxonin loss-of-function contributes to nerve pathology beyond inherited GAN mutations.\",\n      \"method\": \"Whole-genome microarray screen, quantitative PCR validation, Western blot in mouse spinal dorsal horn tissue\",\n      \"journal\": \"Biological research for nursing\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — expression-level finding with validation but no mechanistic pathway placement beyond expression change\",\n      \"pmids\": [\"19398414\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"Gigaxonin (encoded by GAN/KLHL16) is a BTB-Kelch domain protein that functions as a substrate adaptor for the Cul3-based E3 ubiquitin ligase complex; it binds ubiquitin-activating enzyme E1 through its BTB domain and engages substrates — including MAP1B light chain, TBCB, vimentin, peripherin, and neurofilament proteins — through its kelch repeat beta-propeller domain, targeting them for proteasomal degradation, such that loss-of-function mutations cause pathological accumulation of intermediate filaments and cytoskeletal proteins leading to giant axonal neuropathy.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"Gigaxonin, encoded by GAN (also known as KLHL16), is a BTB-Kelch family E3 ubiquitin ligase adaptor protein that targets intermediate filament proteins—including neurofilaments, vimentin, and GFAP—for ubiquitin-proteasome-mediated degradation, binding substrates through its C-terminal Kelch repeat domain and associating with the ubiquitin-conjugation machinery via its N-terminal BTB domain [PMID:17587580, PMID:27023907]. In astrocytes, loss of gigaxonin leads to perinuclear accumulation of vimentin and GFAP aggregates, with vimentin augmenting GFAP oligomerization and aggregation, and GAN patient iPSC-derived astrocytes are deficient for gigaxonin protein [PMID:37672338]. Loss-of-function mutations across the BTB, BACK, and Kelch domains of gigaxonin cause giant axonal neuropathy, an autosomal recessive neurodegenerative disorder characterized by swollen axons filled with accumulated neurofilaments [PMID:27023907, PMID:34889507, PMID:32158379].\",\n  \"teleology\": [\n    {\n      \"year\": 2007,\n      \"claim\": \"Establishing gigaxonin as an E3 ubiquitin ligase adaptor resolved the mechanistic basis of giant axonal neuropathy: gigaxonin binds ubiquitin-activating enzyme E1 N-terminally and microtubule-associated proteins C-terminally, targeting them for degradation, and disease mutations impede this process.\",\n      \"evidence\": \"Genotype-phenotype analysis combined with prior biochemical characterization of gigaxonin interactions\",\n      \"pmids\": [\"17587580\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Based on summary of prior biochemical work rather than direct reconstitution in this paper\",\n        \"Identity of the direct E3 ligase complex (CUL3-based or other) not dissected\",\n        \"Relative contributions of individual substrate classes (MAPs vs intermediate filaments) to disease not resolved\"\n      ]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Systematic mapping of disease mutations across the BTB, BACK, and Kelch domains established that all three functional regions are essential, linking homodimerization (BTB), scaffold integrity (BACK), and substrate recognition (Kelch) to intermediate filament processing in neurons and vimentin turnover in fibroblasts.\",\n      \"evidence\": \"Database analysis of GAN mutations combined with domain-function mapping from prior studies\",\n      \"pmids\": [\"27023907\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No direct biochemical measurement of how individual mutations alter ubiquitin ligase activity\",\n        \"Structural basis of substrate selectivity within the Kelch domain not determined\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Identification of compound heterozygous mutations affecting conserved residues in both the BTB (p.S79L) and Kelch (p.T489S) domains, with classical giant axon histopathology, reinforced that disruption of either domain is sufficient to produce the disease phenotype.\",\n      \"evidence\": \"Next-generation sequencing, computational structural prediction, sural nerve biopsy histology in a single patient\",\n      \"pmids\": [\"32158379\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"Structural predictions are computational and not validated experimentally\",\n        \"Individual contribution of each mutation not separated\",\n        \"Single patient without functional rescue\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Demonstrating that a splice-site mutation (c.1373+1G>A) causes exon 8 skipping and disrupts Kelch domain formation established that Kelch domain integrity is required for gigaxonin function in vivo.\",\n      \"evidence\": \"Whole-exome sequencing with cDNA-level validation of aberrant splicing in a patient family\",\n      \"pmids\": [\"34889507\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single family; no protein-level or functional rescue experiments performed\",\n        \"Whether truncated protein is expressed or degraded by NMD not determined\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Patient iPSC-derived astrocytes revealed that gigaxonin deficiency causes perinuclear vimentin and GFAP accumulation, and that vimentin augments GFAP aggregation, extending the disease mechanism beyond neurons to astrocytes and identifying an intermediate filament co-aggregation phenomenon.\",\n      \"evidence\": \"iPSC differentiation to astrocytes and brain organoids from GAN patient fibroblasts, CRISPR/Cas9 isogenic controls, immunofluorescence, overexpression, FISH\",\n      \"pmids\": [\"37672338\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether gigaxonin directly ubiquitinates GFAP or acts indirectly through vimentin not resolved\",\n        \"In vivo relevance of astrocyte pathology to disease progression not established\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The precise CUL3-containing E3 ligase complex through which gigaxonin operates, the structural basis of substrate selectivity, and the relative contribution of neuronal versus glial intermediate filament accumulation to disease pathogenesis remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No in vitro reconstitution of the gigaxonin-CUL3 ubiquitin ligase complex with purified substrates\",\n        \"No structural model of gigaxonin-substrate interaction at atomic resolution\",\n        \"Therapeutic rescue of intermediate filament clearance not demonstrated in vivo\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 1, 3]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"vimentin\", \"GFAP\"],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"Gigaxonin is a BTB-Kelch substrate adaptor for the Cul3-based E3 ubiquitin ligase complex that targets cytoskeletal and intermediate filament proteins for proteasomal degradation. Its N-terminal BTB domain binds ubiquitin-activating enzyme E1 and mediates Cul3 interaction, while its C-terminal kelch-repeat β-propeller engages substrates including MAP1B light chain, tubulin folding cofactor B (TBCB), vimentin, peripherin, GFAP, and neurofilament proteins, promoting their ubiquitin-dependent turnover [PMID:16227972, PMID:16303566, PMID:23585478]. Loss-of-function mutations in GAN cause giant axonal neuropathy, a severe autosomal recessive sensorimotor neuropathy characterized by pathological accumulation of intermediate filaments and cytoskeletal proteins in neurons, astrocytes, and fibroblasts [PMID:11062483, PMID:37672338]. Patient-derived iPSC models demonstrate that vimentin is an early effector of gigaxonin deficiency, with perinuclear vimentin aggregates driving secondary GFAP accumulation and abnormal nuclear morphology in astrocytes [PMID:37672338].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Positional cloning identified GAN as the causative gene for giant axonal neuropathy, revealing a novel BTB-kelch domain protein whose loss-of-function mutations cause generalized intermediate filament disorganization — establishing that a single E3-adaptor-like protein governs IF homeostasis.\",\n      \"evidence\": \"Positional cloning and mutation screening in GAN patient families\",\n      \"pmids\": [\"11062483\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No biochemical substrates or binding partners identified at this stage\", \"Mechanism of IF accumulation unknown\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Discovery that gigaxonin directly binds MAP1B light chain via its kelch repeats identified the first substrate interaction and linked gigaxonin to microtubule stability and axonal transport, with disease mutations abolishing this binding.\",\n      \"evidence\": \"Yeast two-hybrid, reciprocal co-IP, co-localization in neurons, disease-mutation disruption\",\n      \"pmids\": [\"12147674\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether gigaxonin promotes MAP1B-LC degradation or merely sequesters it was unclear\", \"Other substrates not yet tested\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Three convergent studies established gigaxonin as a ubiquitin-proteasome pathway adaptor: it drives proteasomal degradation of MAP1B-LC and TBCB, binds E1 via its BTB domain, and is itself ubiquitinated by a Cul3-dependent complex — placing it firmly in the BTB-Kelch/Cul3 E3 ligase system and demonstrating that substrate accumulation upon gigaxonin loss is directly neurotoxic.\",\n      \"evidence\": \"GAN-null mouse neurons with rescue and survival assays (MAP1B-LC); co-IP with proteasome inhibitor block (TBCB); in vivo Cul3-dependent ubiquitination assays\",\n      \"pmids\": [\"16227972\", \"16303566\", \"15983046\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether gigaxonin directly ubiquitinates substrates or recruits Cul3 to do so was not resolved biochemically\", \"Intermediate filament proteins not yet tested as substrates\", \"Structural basis of kelch–substrate interaction unknown\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Extension of gigaxonin's substrate repertoire to intermediate filament proteins — vimentin in fibroblasts and peripherin/neurofilaments in neurons — demonstrated that gigaxonin is a master regulator of IF turnover, not only of MAPs, providing the molecular explanation for the hallmark IF aggregates in GAN.\",\n      \"evidence\": \"GAN patient fibroblasts, Gan−/− mouse neurons, gigaxonin overexpression/MG-132 proteasome inhibition, immunoblot and immunofluorescence\",\n      \"pmids\": [\"23585478\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether gigaxonin targets all IF classes or only neuronal and type III IFs is unclear\", \"Precise ubiquitination sites on IF substrates not mapped\", \"No reconstituted in vitro ubiquitination assay with purified components\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Patient iPSC-derived astrocytes and brain organoids revealed that vimentin is the earliest effector of gigaxonin loss, with vimentin aggregates secondarily promoting GFAP accumulation and trapping KLHL16 mRNA — establishing a feed-forward aggregation mechanism in astrocytes.\",\n      \"evidence\": \"GAN patient iPSC-derived NPCs, astrocytes, and brain organoids with CRISPR isogenic controls; overexpression assays; RNA FISH\",\n      \"pmids\": [\"37672338\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether mRNA trapping by vimentin aggregates reduces gigaxonin protein and worsens pathology in vivo is untested\", \"Contribution of astrocyte dysfunction vs. neuronal pathology to disease progression not delineated\", \"No therapeutic rescue demonstrated in organoid model\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key open questions include the structural basis of kelch-domain substrate recognition, whether gigaxonin directly assembles a Cul3-RING catalytic complex for substrate ubiquitination (vs. indirect degradation routes), and the relative contribution of individual substrate accumulation to neurodegeneration in vivo.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No crystal or cryo-EM structure of gigaxonin–substrate complex\", \"No reconstituted Cul3–gigaxonin ubiquitination assay with defined substrates\", \"Relative pathogenic contribution of MAP1B-LC, TBCB, and IF accumulation not resolved in animal models\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [2, 3, 4, 6]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [1, 2, 3, 6]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [1, 6, 8]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [2, 6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [2, 3, 4, 6]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [0, 2, 6, 8]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [0, 5, 8]}\n    ],\n    \"complexes\": [\n      \"Cul3-BTB-Kelch E3 ubiquitin ligase complex\"\n    ],\n    \"partners\": [\n      \"MAP1B\",\n      \"TBCB\",\n      \"CUL3\",\n      \"VIM\",\n      \"PRPH\",\n      \"GFAP\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}